Guardian Pharmacy Services, Inc. (GRDN) is a publicly traded Healthcare sector company. As of September 1, 2026, GRDN trades at $38.36 with a market cap of $2.35B and a P/E ratio of 0.00. GRDN moved +4.07% today. Year to date, GRDN is +31.63%; over the trailing twelve months it is +46.13%. Its 52-week range spans $17.78 to $47.02. Analyst consensus is strong buy with an average price target of $49.00. Rallies surfaces GRDN's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks hedge fund and 13F ownership for GRDN, including fund holders, share counts, and position changes when data is available.
| Metric | Value |
|---|---|
| Price | $38.36 |
| Market Cap | $2.35B |
| P/E Ratio | 0.00 |
| EPS | $0.00 |
| Dividend Yield | 0.00% |
| 52-Week High | $47.02 |
| 52-Week Low | $17.78 |
| Volume | 467.74K |
| Avg Volume | 0 |
| Revenue (TTM) | $1.46B |
| Net Income | $66.52M |
| Gross Margin | 21.63% |
5 analysts cover GRDN: 0 strong buy, 5 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $49.00.